Implantica AG (FRA:8IM1)

Implantica AG Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	2.07	1.94	1.41	0.84	0.39
Revenue Growth (YoY)	7.08%	37.50%	67.22%	117.57%	154.60%
Cost of Revenue	2.62	3.05	1.32	1.26	1.25
Gross Profit	-0.55	-1.12	0.09	-0.42	-0.87
Selling, General & Admin	12.62	12.16	14.95	12.22	5.93
Research & Development	7.35	12.19	7.02	5.81	6.34
Other Operating Expenses	-	-	-0.03	-	-
Operating Expenses	19.97	24.35	21.93	18.03	12.27
Operating Income	-20.52	-25.47	-21.84	-18.45	-13.14
Interest Expense	-0.2	-0.05	-0.03	-0.34	-0.64
Interest & Investment Income	0.94	0.79	0.68	0.04	-
Currency Exchange Gain (Loss)	-	1.11	-3.19	-2.63	-1.65
Other Non Operating Income (Expenses)	-	-0.02	-0.05	-0.03	-0.02
Pretax Income	-19.78	-23.64	-24.43	-21.4	-15.45
Income Tax Expense	0.03	0.05	0.07	-0.04	0.02
Earnings From Continuing Operations	-19.82	-23.69	-24.5	-21.36	-15.47
Minority Interest in Earnings	0.19	0.35	0.76	0.54	0.11
Net Income	-19.63	-23.33	-23.74	-20.82	-15.36
Net Income to Common	-19.63	-23.33	-23.74	-20.82	-15.36
Shares Outstanding (Basic)	283	283	283	283	282
Shares Outstanding (Diluted)	283	283	283	283	282
Shares Change (YoY)	0.04%	0.01%	-0.01%	0.56%	6.82%
EPS (Basic)	-0.07	-0.08	-0.08	-0.07	-0.05
EPS (Diluted)	-0.07	-0.08	-0.08	-0.07	-0.05
Free Cash Flow	-16.63	-22.79	-20	-16.02	-11.64
Free Cash Flow Per Share	-0.06	-0.08	-0.07	-0.06	-0.04
Gross Margin	-26.48%	-57.65%	6.46%	-50.00%	-224.03%
Operating Margin	-990.01%	-1315.39%	-1551.14%	-2190.86%	-3395.61%
Profit Margin	-946.74%	-1205.22%	-1686.36%	-2473.16%	-3969.25%
Free Cash Flow Margin	-802.03%	-1177.22%	-1420.10%	-1902.49%	-3006.72%
EBITDA	-20.26	-25.39	-21.77	-18.39	-13.1
D&A For EBITDA	0.27	0.07	0.07	0.06	0.04
EBIT	-20.52	-25.47	-21.84	-18.45	-13.14

Source: S&P Global Market Intelligence. Standard template. Financial Sources.